Historique
FRANÇAIS :
Les peines prononcées à l'encontre des délinquants pour des infractions liées à la drogue à travers l'Union européenne sont examinées pour la première fois dans la présente «Question spécifique». En analysant les statistiques les pl[...]
Éditeur Publications Office of the European Union
191 Documents disponibles chez cet éditeur
This study explores the civil society organisations that engage in drug policy advocacy in Europe. An Internet search in English, French and Spanish combined with information from national sources in 30 countries identified 218 organisations act[...]
This paper describes the development and main characteristics of drug policy in Austria. It traces the development of Austrian drug laws from the time of the Austro-Hungarian Empire through to the present day. Austria's drug policy has several d[...]
This paper describes the development and main characteristics of drug policy in Poland. It starts with the early days of drug control in Poland in the 1920s, describes the changes related to the emergence of Polish heroin - Kompot - in the late [...]
The national drug policy of Ireland comes under the spotlight in the second volume in the EMCDDA series of Drug policy profiles. Examining the evolution of Irish drug policy through four periods of historic development, the report explores: the [...]
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU. This includes describing the 'pre-precursor' phenomenon and r[...]
This report considers substance use prevention in Europe through the lens of a system, highlighting the wide range of factors that need to be addressed to successfully implement substance use prevention programmes and policies. They are consider[...]
This publication provides an update on drug-related deaths in Europe, presenting and analysing the latest data and trends in drug-induced deaths and overall mortality among high-risk drug users in the European Union and beyond. It draws on contr[...]
This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deat[...]
This report is part of the EMCDDA activity around the development and improvement of drug supply indicators, which are designed to reflect developments in drug markets as well as the markets' wider harms and impact. The protocol in this document[...]
Homicide is a violent act that generates high social costs. In particular, drug-related homicide (DRH) has the potential to act as an indicator of wider drug-related crime. Comparing DRH levels between countries with data on this topic can be a [...]
OEDT = EMCDDA ; I. GIRAUDON ; A. M. DINES ; N. SINGLETON ; A. NOOR ; P. I. DARGAN ; D. WOOD | 2020
RapportENGLISH: This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of th[...]
This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020, while high[...]
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up [...]
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report [...]
